This is a case about a company, PharmacyChecker.com, that, for over 20 years, has provided pharmacy verification services and information that helps consumers identify online pharmacies that sell genuine, safe and affordable prescription medication to treat conditions such as high blood pressure, asthma, and diabetes. For much of that time, Big Pharma has funded organizations and campaigns that misinform the public about online pharmacies, importation, and drug prices. They have sought to discredit PharmacyChecker’s mission to help patients struggling with high prescription drug costs. The case, which has been filed in New York and Oregon against multiple defendants, alleges an unlawful conspiracy to suppress the information that PharmacyChecker provides to the public.

We are pleased with the March 2024 ruling in the U.S. District Court for the Southern District of New York in which U.S. District Judge Kenneth M. Karas denied the National Association of Boards of Pharmacy’s (NABP) motion to dismiss PharmacyChecker’s Lanham Act claim against it. PharmacyChecker will continue to pursue its case against the NABP in New York.

In January 2024, in a ruling issued by U.S. District Judge Michael H. Simon, PharmacyChecker defeated a motion filed by LegitScript to dismiss PharmacyChecker’s case against it in Oregon. PharmacyChecker will proceed to prosecute its antitrust claim against LegitScript.

With the Oregon court agreeing with PharmacyChecker’s positions on key issues of fact and law, PharmacyChecker also plans to appeal the New York district court’s April 2023 decision, which stalled the antitrust claims against alleged co-conspirators The Alliance for Safe Online Pharmacies, Center for Safe Internet Pharmacies, National Association of Board of Pharmacy and the Partnership for Safe Medicines. We believe such an appeal will allow the New York case to move forward.

PharmacyChecker looks forward to continuing its fight for competition and transparency in prescription drug pricing.